Jeffrey W. Sherman
Executive V.P., NEOPHARM INC.
Companies
- Zafgen (United States)Board member Oct 5, 2023 to now1
- Xeris Biopharma Holdings, Inc.Board member Oct 5, 2021 to now2
- Horizon Therapeutics Public Ltd CoEVP & Chief Medical Officer Jul 28, 2011 to Oct 6, 20233
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Xeris Biopharma Holdings, Inc. XERS224,588 shares4$2.5M at $11.04Aug 29, 2025
- Zafgen (United States) LRMR5,000 shares5$10.6K at $2.11Feb 27, 2026
- Horizon Therapeutics Public Ltd Co0 shares6Oct 6, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 27, 2026Bought 5,000 shares at $5.00 of Zafgen (United States)5
- Aug 28, 2025Sold 42,232 shares at $7.92 of Xeris Biopharma Holdings, Inc.4
- Aug 28, 2025Exercised options 47,040 shares at $6.66 of Xeris Biopharma Holdings, Inc.4
- Jun 4, 2025Granted 50,000 shares of Xeris Biopharma Holdings, Inc.7
- Jun 5, 2024Granted 50,000 shares of Xeris Biopharma Holdings, Inc.8
- Mar 15, 2024Other 6,502 shares of Xeris Biopharma Holdings, Inc.9
- Nov 27, 2023Bought 5,400 shares at $1.87 of Xeris Biopharma Holdings, Inc.10
- Oct 6, 2023Returned to company 45,352 shares at $116.50 of Horizon Therapeutics Public Ltd Co6
- Oct 6, 2023Returned to company 80,944 shares at $116.50 of Horizon Therapeutics Public Ltd Co6
- Oct 6, 2023Returned to company 105,808 shares at $116.50 of Horizon Therapeutics Public Ltd Co6
- Oct 6, 2023Returned to company 2,655 shares at $116.50 of Horizon Therapeutics Public Ltd Co6
- Sep 6, 2023Gift 2,165 shares of Horizon Therapeutics Public Ltd Co11
- Jun 7, 2023Granted 42,500 shares of Xeris Biopharma Holdings, Inc.12
- Jan 17, 2023Gift 33,795 shares of Horizon Therapeutics Public Ltd Co13
- Jan 17, 2023Gift 33,795 shares of Horizon Therapeutics Public Ltd Co13
- Jan 11, 2023Sold 3,368 shares at $113.10 of Horizon Therapeutics Public Ltd Co14
- Jan 10, 2023Sold 3,368 shares at $113.05 of Horizon Therapeutics Public Ltd Co14
- Jan 6, 2023Sold 5,187 shares at $113.29 of Horizon Therapeutics Public Ltd Co15
- Jan 5, 2023Shares withheld for tax 22,655 shares at $113.24 of Horizon Therapeutics Public Ltd Co15
- Jan 5, 2023Exercised options 51,132 shares of Horizon Therapeutics Public Ltd Co15
- Jan 1, 2023Shares withheld for tax 9,717 shares at $113.80 of Horizon Therapeutics Public Ltd Co16
- Jan 1, 2023Exercised options 21,772 shares of Horizon Therapeutics Public Ltd Co16
- Dec 12, 2022Sold 21,378 shares at $111.45 of Horizon Therapeutics Public Ltd Co17
- Dec 12, 2022Sold 6,974 shares at $111.44 of Horizon Therapeutics Public Ltd Co17
- Jun 8, 2022Granted 15,000 shares of Xeris Biopharma Holdings, Inc.18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARZafgen (United States), Board member
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 4, 2025
- 8SEC EDGARForm 4 filed Jun 5, 2024
- 9SEC EDGARForm 4 filed Apr 11, 2024
- 10SEC EDGARForm 4 filed Nov 29, 2023
- 11SEC EDGARForm 4 filed Sep 7, 2023
- 12SEC EDGARForm 4 filed Jun 7, 2023
- 13SEC EDGARForm 4 filed Jan 18, 2023
- 14SEC EDGARForm 4 filed Jan 12, 2023
- 15SEC EDGARForm 4 filed Jan 6, 2023
- 16SEC EDGARForm 4 filed Jan 4, 2023
- 17SEC EDGARForm 4 filed Dec 13, 2022
- 18SEC EDGARForm 4 filed Jun 9, 2022